AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Prestige Consumer Healthc... (PBH)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

85.44

-0.56 (-0.65%)

At close: Feb 18, 2025, 3:59 PM

85.19

-0.29%

After-hours: Feb 18, 2025, 07:00 PM EST

undefined% (undefined)

Bid	84.79
Market Cap	4.23B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	4.26
PE Ratio (ttm)	20.06
Forward PE	n/a
Analyst	Strong Buy

Ask	85.59
Volume	160,444
Avg. Volume (20D)	287,883
Open	85.82
Previous Close	86.00
Day's Range	85.14 - 86.51
52-Week Range	62.35 - 88.36
Beta	undefined

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, ...

[Show more]

Industry Medical - Distribution

Sector Healthcare

IPO Date Feb 10, 2005

Employees 570

Stock Exchange NYSE

Ticker Symbol PBH

Website https://www.prestigebrands.com

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for PBH stock is "Strong Buy." The 12-month stock price forecast is $96.5, which is an increase of 12.95% from the latest price.

Buy 75.00%

Hold 25.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Prestige Consumer Healthcare Inc. is scheduled to release its earnings on May 13, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+14.78%

Prestige Consumer Healthcare shares are trading hi... Unlock content with Pro Subscription

9 months ago

-7.01%

Prestige Consumer shares are trading lower after the company reported worse-than-expected Q4 financial results and issued weak guidance.

News

1 day ago · zacks.com

PBH or BSX: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those...

1 week ago · zacks.com

PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8%

Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand.

1 week ago · seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript

Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2025 Results Conference Call February 6, 2025 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chair...

1 week ago · zacks.com

Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ago...

2 weeks ago · zacks.com

PBH vs. BSX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents invest...

3 weeks ago · zacks.com

Prestige Consumer Stock Up 29.9% in a Year: What's Behind the Surge?

PBH sees remarkable gains from long-term brand-building strategies and developing the e-commerce channel.

1 month ago · zacks.com

5 Beaten-Down MedTech Stocks Set to Rebound in 2025

Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.

1 month ago · zacks.com

Should Prestige Consumer Stock Stay in Your Portfolio Right Now?

Investors remain optimistic about PBH stock due to its strong focus on brand building.

2 months ago · zacks.com

PBH or ABT: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the bett...

2 months ago · seekingalpha.com

Premium Brands Holdings: Serving Up Protein On Both Sides Of The Border

Premium Brands Holdings has expanded from Western Canada to the US, focusing on specialty foods and wholesale distribution through acquisitions. PBH aims for $10B annual revenue by 2027, leveraging a ...

Load More News